Retrieve available abstracts of 30 articles: HTML format
Single Articles
June 2025
MILA-ALOMA M, Tosun D, Schindler SE, Hausle I, et al Timing of Changes in Alzheimer's Disease Plasma Biomarkers as Assessed by Amyloid
and Tau PET Clocks.
Ann Neurol. 2025 Jun 20. doi: 10.1002/ana.27285. PubMedAbstract available
IAZZOLINO B, Palumbo F, Moglia C, Manera U, et al Frequency and Early Predictors of Cognitive Deterioration in Amyotrophic Lateral
Sclerosis: A Longitudinal Population-Based Study.
Ann Neurol. 2025;97:1122-1133. PubMedAbstract available
May 2025
BRAUN AS, Satoh R, Pham NTT, Singh-Reilly N, et al Machine Learning Models of Voxel-Level [(18)F] Fluorodeoxyglucose Positron
Emission Tomography Data Excel at Predicting Progressive Supranuclear Palsy
Pathology.
Ann Neurol. 2025 May 30. doi: 10.1002/ana.27265. PubMedAbstract available
April 2025
LUO C, Nguyen TN, Li R, Tao C, et al Computed Tomography Perfusion Parameters: A Potential Tool for Treatment
Selection in Basilar Artery Occlusion.
Ann Neurol. 2025 Apr 2. doi: 10.1002/ana.27214. PubMedAbstract available
BROWN EG, Chahine LM, Siderowf A, Gochanour C, et al Staged Screening Identifies People with Biomarkers Related to Neuronal
Alpha-Synuclein Disease.
Ann Neurol. 2025;97:730-740. PubMedAbstract available
March 2025
DZIALAS V, Bischof GN, Mollenhoff K, Drzezga A, et al Dopamine Transporter Imaging as Objective Monitoring Biomarker in Parkinson's
Disease.
Ann Neurol. 2025 Mar 27. doi: 10.1002/ana.27223. PubMedAbstract available
LAGARDE J, Maiti P, Schonhaut DR, Blazhenets G, et al Amyloid PET in Sporadic Early- Versus Late-Onset Alzheimer's Disease: Comparison
of the LEADS and ADNI Cohorts.
Ann Neurol. 2025 Mar 17. doi: 10.1002/ana.27233. PubMedAbstract available
ARRIOLA-INFANTE JE, Morcillo-Nieto AO, Zsadanyi SE, Franquesa-Mullerat M, et al Regional Brain Metabolism across the Alzheimer's Disease Continuum in Down
Syndrome.
Ann Neurol. 2025 Mar 14. doi: 10.1002/ana.27226. PubMedAbstract available
February 2025
CANOSA A, Manera U, Vasta R, Zocco G, et al Brain Metabolic Features of FUS-ALS: A 2-[(18)F]FDG-PET Study.
Ann Neurol. 2025 Feb 20. doi: 10.1002/ana.27201. PubMedAbstract available
KEUM M, Byun MS, Yi D, Ahn H, et al The Use of Antihypertensive Medication and In Vivo Alzheimer's Disease Pathology.
Ann Neurol. 2025 Feb 17. doi: 10.1002/ana.27204. PubMedAbstract available
January 2025
LI J, Chen D, Tang Y, Chen Z, et al Synaptic Density Reductions in MSA: A Potential Biomarker Identified Through
[(18)F]SynVesT-1 PET Imaging.
Ann Neurol. 2025 Jan 19. doi: 10.1002/ana.27179. PubMedAbstract available
December 2024
KIM N, Ryu WS, Ha SY, Kim JY, et al Optimal Cerebral Blood Flow Thresholds for Ischemic Core Estimation Using
Computed Tomography Perfusion and Diffusion-Weighted Imaging.
Ann Neurol. 2024 Dec 26. doi: 10.1002/ana.27169. PubMedAbstract available
BRIER MR, Judge B, Ying C, Salter A, et al Increased White Matter Aerobic Glycolysis in Multiple Sclerosis.
Ann Neurol. 2024 Dec 23. doi: 10.1002/ana.27165. PubMedAbstract available
October 2024
ENGELS-DOMINGUEZ N, Riphagen JM, Van Egroo M, Koops EA, et al Lower Locus Coeruleus Integrity Signals Elevated Entorhinal Tau and Clinical
Progression in Asymptomatic Older Individuals.
Ann Neurol. 2024;96:650-661. PubMedAbstract available
September 2024
MUTIMER CA, Mujanovic A, Kaesmacher J, Churilov L, et al Comparison of Perfusion Imaging Definitions of the No-Reflow Phenomenon after
Thrombectomy-What Is the Best Perfusion Imaging Definition?
Ann Neurol. 2024 Sep 3. doi: 10.1002/ana.27073. PubMedAbstract available
BRUMBERG J, Blazhenets G, Buhler S, Fostitsch J, et al Cerebral Glucose Metabolism Is a Valuable Predictor of Survival in Patients with
Lewy Body Diseases.
Ann Neurol. 2024;96:539-550. PubMedAbstract available
August 2024
BITZER F, Walger L, Bauer T, Schulte F, et al Higher Validity, Lower Radiation: A New Ictal Single-Photon Emission Computed
Tomography Framework.
Ann Neurol. 2024 Aug 21. doi: 10.1002/ana.27061. PubMedAbstract available
HIRATA K, Matsuoka K, Tagai K, Endo H, et al In Vivo Assessment of Astrocyte Reactivity in Patients with Progressive
Supranuclear Palsy.
Ann Neurol. 2024;96:247-261. PubMedAbstract available
June 2024
SOLEIMANI-MEIGOONI DN, Smith R, Provost K, Lesman-Segev OH, et al Head-to-Head Comparison of Tau and Amyloid Positron Emission Tomography Visual
Reads for Differential Diagnosis of Neurodegenerative Disorders: An
International, Multicenter Study.
Ann Neurol. 2024 Jun 18. doi: 10.1002/ana.27008. PubMedAbstract available
May 2024
SAARINEN EK, Kuusimaki T, Lindholm K, Niemi K, et al Dietary Caffeine and Brain Dopaminergic Function in Parkinson Disease.
Ann Neurol. 2024 May 20. doi: 10.1002/ana.26957. PubMedAbstract available
LAN G, Chen X, Yang J, Sun P, et al Microglial Reactivity Correlates with Presynaptic Loss Independent of beta-Amyloid
and Tau.
Ann Neurol. 2024;95:917-928. PubMedAbstract available
April 2024
GARCIA-CORDERO I, Anastassiadis C, Khoja A, Morales-Rivero A, et al Evaluating the Effect of Alzheimer's Disease-Related Biomarker Change in
Corticobasal Syndrome and Progressive Supranuclear Palsy.
Ann Neurol. 2024 Apr 5. doi: 10.1002/ana.26930. PubMedAbstract available
March 2024
ARNALDI D, Mattioli P, Raffa S, Pardini M, et al Presynaptic Dopaminergic Imaging Characterizes Patients with REM Sleep Behavior
Disorder Due to Synucleinopathy.
Ann Neurol. 2024 Mar 11. doi: 10.1002/ana.26902. PubMedAbstract available
PAPP KV, Jutten RJ, Soberanes D, Weizenbaum E, et al Early Detection of Amyloid-Related Changes in Memory among Cognitively Unimpaired
Older Adults with Daily Digital Testing.
Ann Neurol. 2024;95:507-517. PubMedAbstract available
February 2024
LI Y, Yen D, Hendrix RD, Gordon BA, et al Timing of Biomarker Changes in Sporadic Alzheimer's Disease in Estimated Years
from Symptom Onset.
Ann Neurol. 2024 Feb 24. doi: 10.1002/ana.26891. PubMedAbstract available
CHEN X, Toueg TN, Harrison TM, Baker SL, et al Regional Tau Deposition Reflects Different Pathways of Subsequent
Neurodegeneration and Memory Decline in Cognitively Normal Older Adults.
Ann Neurol. 2024;95:249-259. PubMedAbstract available
December 2023
BONOMI S, Lu R, Schindler SE, Bui Q, et al Relationships of Cognitive Measures with Cerebrospinal Fluid but not Imaging
Biomarkers of Alzheimer Disease Vary between Black and White Individuals.
Ann Neurol. 2023 Dec 1. doi: 10.1002/ana.26838. PubMedAbstract available
November 2023
CHUN MY, Chung SJ, Kim SH, Park CW, et al Hippocampal Perfusion Affects Motor and Cognitive Functions in Parkinson's
Disease: An Early-Phase (18) F-FP-CIT PET Study.
Ann Neurol. 2023 Nov 14. doi: 10.1002/ana.26827. PubMedAbstract available
October 2023
ZHENG L, Rubinski A, Dennecke J, Luan Y, et al Combined Connectomics, MAPT Gene Expression, and Amyloid Deposition to Explain
Regional Tau Deposition in Alzheimer's Disease.
Ann Neurol. 2023 Oct 14. doi: 10.1002/ana.26818. PubMedAbstract available
July 2023
PISANI L, Haussen DC, Mohammaden M, Perry da Camara C, et al Comparison of CT Perfusion Software Packages for Thrombectomy Eligibility.
Ann Neurol. 2023 Jul 25. doi: 10.1002/ana.26748. PubMedAbstract available